Literature DB >> 7319478

Analysis of human fibrinopeptides by high-performance liquid chromatography.

M Kehl, F Lottspeich, A Henschen.   

Abstract

During coagulation, fibrinogen is cleaved by thrombin, whereby fibrin and low molecular mass peptides, the so-called fibrinopeptides, are released. A novel method, employing high-performance liquid chromatography, has been developed for the separation and quantitation of these peptides. For the chromatography a reversed phase column was used. The fibrinopeptides were detected by their UV-absorption at 210 nm, peptides released from 0.1 mg of fibrinogen being easily detected. The procedure offers for the first time the possibility of determining all human fibrinopeptides and their degradation products in a single analysis. It is eminently suited for fibrinopeptide preparation and studies of fibrinopeptide release kinetics and genetically abnormal fibrinopeptides.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7319478

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  11 in total

1.  Polymerization of rod-like macromolecular monomers studied by stopped-flow, multiangle light scattering: set-up, data processing, and application to fibrin formation.

Authors:  S Bernocco; F Ferri; A Profumo; C Cuniberti; M Rocco
Journal:  Biophys J       Date:  2000-07       Impact factor: 4.033

2.  A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen.

Authors:  D K Galanakis; B Ghebrehiwet
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

3.  Fibrinogen Stony Brook, a heterozygous A alpha 16Arg----Cys dysfibrinogenemia. Evaluation of diminished platelet aggregation support and of enhanced inhibition of fibrin assembly.

Authors:  D K Galanakis; A Henschen; E I Peerschke; M Kehl
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

4.  Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors.

Authors:  J Hofsteenge; H Taguchi; S R Stone
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

5.  Fibrinogen Lima: a homozygous dysfibrinogen with an A alpha-arginine-141 to serine substitution associated with extra N-glycosylation at A alpha-asparagine-139. Impaired fibrin gel formation but normal fibrin-facilitated plasminogen activation catalyzed by tissue-type plasminogen activator.

Authors:  H Maekawa; K Yamazumi; S Muramatsu; M Kaneko; H Hirata; N Takahashi; C L Arocha-Piñango; S Rodriguez; H Nagy; J L Perez-Requejo
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr.

Authors:  J Koopman; F Haverkate; S T Lord; J Grimbergen; P M Mannucci
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

7.  Spontaneous reversal of acquired autoimmune dysfibrinogenemia probably due to an antiidiotypic antibody directed to an interspecies cross-reactive idiotype expressed on antifibrinogen antibodies.

Authors:  A Ruiz-Arguelles
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

8.  Fibrinogen Manchester. Detection of a heterozygous phenotype in the intraplatelet pool.

Authors:  C Southan; D A Lane; I Knight; H Ireland; J Bottomley
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

9.  Fibrinogen Osaka IV: a congenital dysfibrinogenemia found in a patient originally reported in relation to surgery, now defined to have an A alpha arginine-16 to histidine substitution.

Authors:  K Yamazumi; S Terukina; M Matsuda; J Kanbayashi; M Sakon; T Tsujinaka
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  Purification and characterization by fast-atom-bombardment mass spectrometry of the polymorphonuclear-leucocyte-elastase-generated A alpha (1-21) fragment of fibrinogen from human blood after incubation with calcium ionophore A23187.

Authors:  R S Dewey; J M Liesch; H R Williams; E E Sugg; C A Dolan; P Davies; R A Mumford; G Albers-Schönberg
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.